HHS Announces New Reporting and Testing Requirements for Nursing Homes and other Providers
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On Tuesday, August 25 the Department of Health and Human Services announced regulatory changes through an interim final rule from the Centers for Medicare & Medicaid Services (CMS). The rule would require all Medicare-certified nursing homes to test their staff for COVID-19 and requires that they offer tests to residents.
While prior CMS testing guidance for nursing homes have taken the form of recommendations rather than mandates, the agency intends to begin enforcing adherence to staff testing requirements for these facilities through sanctions ranging from $400 per day to over $8,000 for an instance of noncompliance.
The enhancements being made to testing rules and enforcement follows last month’s announcement of a new HHS program, which would provide one time shipments of point-of-care antigen testing instruments to prioritized nursing homes across the U.S. by the end of September.
CMS is recommending that the frequency of staff testing be based on the “degree of community spread”, which is determined by the amount of COVID-19 infections both within the facility and in the surrounding community. To cover testing expenses, the agency previously announced the distribution of $2.5 billion from the $175 billion CARES Act Provider Relief Fund, which supplements the $4.9 billion previously distributed to skilled nursing facilities. In addition to funding, the agency is also offering new training courses for nursing home staff aimed at mitigating the spread of COVID-19 in these facilities through training and the sharing of best practices.
Nationally, counties own, operate and support 758 skilled nursing facilities and nursing homes, which have been disproportionately impacted by COVID-19. Given the devastating impact of COVID-19 on local economies, regular testing of staff and residents would be unmanageable without sustained Federal investment.
The new rules were announced in conjunction with a larger package of data reporting requirements for hospitals and laboratories which would requires them to report COVID-19 case information to HHS daily or face civil monetary penalties.
The changes are slated to take effect following the 60-day comment period for the interim final rule. NACo will continue to track and report on these and other regulatory changes related to county COVID-19 response efforts.
Additional Resources
- NACo Brief: Nursing Homes and COVID-19
- CMS Press Release: Trump Administration Strengthens COVID-19 Surveillance with New Reporting and Testing Requirements for Nursing Homes, Other Providers
- CMS Interim Final Rule
Attachments
Related News
Congress introduces legislation to restore critical public health funding
On November 14, the Public Health Funding Restoration Act (H. R. 10126/S. 5326) was introduced in both the U.S. Senate and House of Representatives. This legislation would address a pressing need to strengthen the nation’s public health infrastructure through direct and flexible funding to local health entities. By restoring critical funding to the Prevention and Public Health Fund (PPHF), the bill aims to equip communities with the tools needed to tackle modern public health challenges, from chronic disease prevention to emergency response.
CMS finalizes Medicare rule with key improvements for justice-involved populations
On November 1, the Centers for Medicare & Medicaid Services (CMS) published a final rule that, in a major advocacy win for counties, will improving access to Medicare for justice-involved individuals who are in pre-trial status or who are reentering the community. The CY 2025 Medicare Hospital Outpatient Prospective Payment System final rule reflects significant updates to Medicare’s “custody” definition and Special Enrollment Period (SEP) for formerly incarcerated individuals.
Six years of the SUPPORT Act: Ongoing behavioral health policy priorities for counties
On October 24, 2018, the bipartisan SUPPORT Act was enacted. It represented the largest Congressional investment in overdose prevention at the time, aiming to strengthen the nation's response to the substance use crisis.